BeStock  
Stocks › COAG

Hemab Therapeutics Holdings COAG

US equityMarket cap rank #3006
$30.59 −$0.52 (-1.67%)
Pre-market · Oct 6, 6:00 am ET · After hours $30.59 0.00%
Open$31.11
Prev close$31.11
Day range$29.76 – $31.11
Volume294.5K
Market cap$1.43B
P/E (TTM)–
Dividend yield–

COAG Stock News

Headlines matching Hemab Therapeutics Holdings or the COAG ticker, most recent first.

  • H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $60Market news · 12 Aug 2026
  • Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $64Market news · 12 Aug 2026
  • Hemab Therapeutics Holdings, Inc. (COAG) Gets a Buy From WedbushTipRanks · 12 Aug 2026
  • Jefferies Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $47Market news · 14 Jul 2026
  • Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $55Market news · 14 Jul 2026
  • H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $52Market news · 13 Jul 2026
  • Jefferies Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $39Market news · 9 Jun 2026
  • Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $42Market news · 30 Jun 2026
  • Hemab Therapeutics Holdings, Inc. (COAG) Receives a Buy From WedbushTipRanks · 30 Jun 2026
  • H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $40Market news · 27 Jun 2026
  • H.C. Wainwright Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $40Market news · 17 Jun 2026
  • Goldman Sachs Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $36Market news · 26 May 2026
  • Wedbush Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $42Market news · 26 May 2026
  • Evercore Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $50Market news · 26 May 2026
  • Jefferies Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $39Market news · 26 May 2026

Discussion

No comments yet — be the first to weigh in on COAG.

Leave a comment

Scroll to Top